272 related articles for article (PubMed ID: 10187995)
1. The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia.
Bertolino A; Knable MB; Saunders RC; Callicott JH; Kolachana B; Mattay VS; Bachevalier J; Frank JA; Egan M; Weinberger DR
Biol Psychiatry; 1999 Mar; 45(6):660-7. PubMed ID: 10187995
[TBL] [Abstract][Full Text] [Related]
2. The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia.
Bertolino A; Breier A; Callicott JH; Adler C; Mattay VS; Shapiro M; Frank JA; Pickar D; Weinberger DR
Neuropsychopharmacology; 2000 Feb; 22(2):125-32. PubMed ID: 10649825
[TBL] [Abstract][Full Text] [Related]
3. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia.
Bertolino A; Esposito G; Callicott JH; Mattay VS; Van Horn JD; Frank JA; Berman KF; Weinberger DR
Am J Psychiatry; 2000 Jan; 157(1):26-33. PubMed ID: 10618009
[TBL] [Abstract][Full Text] [Related]
4. Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia.
Callicott JH; Bertolino A; Egan MF; Mattay VS; Langheim FJ; Weinberger DR
Am J Psychiatry; 2000 Oct; 157(10):1646-51. PubMed ID: 11007719
[TBL] [Abstract][Full Text] [Related]
5. Cognitive impairment in schizophrenia is associated with prefrontal-striatal functional hypoconnectivity and striatal dopaminergic abnormalities.
Yang KC; Yang BH; Liu MN; Liou YJ; Chou YH
J Psychopharmacol; 2024 Jun; 38(6):515-525. PubMed ID: 38853592
[TBL] [Abstract][Full Text] [Related]
6. Cortical stress regulation is disrupted in schizophrenia but not in clinical high risk for psychosis.
Schifani C; Tseng HH; Kenk M; Tagore A; Kiang M; Wilson AA; Houle S; Rusjan PM; Mizrahi R
Brain; 2018 Jul; 141(7):2213-2224. PubMed ID: 29860329
[TBL] [Abstract][Full Text] [Related]
7. Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging.
Bertolino A; Kumra S; Callicott JH; Mattay VS; Lestz RM; Jacobsen L; Barnett IS; Duyn JH; Frank JA; Rapoport JL; Weinberger DR
Am J Psychiatry; 1998 Oct; 155(10):1376-83. PubMed ID: 9766769
[TBL] [Abstract][Full Text] [Related]
8. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study.
Slifstein M; van de Giessen E; Van Snellenberg J; Thompson JL; Narendran R; Gil R; Hackett E; Girgis R; Ojeil N; Moore H; D'Souza D; Malison RT; Huang Y; Lim K; Nabulsi N; Carson RE; Lieberman JA; Abi-Dargham A
JAMA Psychiatry; 2015 Apr; 72(4):316-24. PubMed ID: 25651194
[TBL] [Abstract][Full Text] [Related]
9. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging.
Bertolino A; Nawroz S; Mattay VS; Barnett AS; Duyn JH; Moonen CT; Frank JA; Tedeschi G; Weinberger DR
Am J Psychiatry; 1996 Dec; 153(12):1554-63. PubMed ID: 8942451
[TBL] [Abstract][Full Text] [Related]
10. Neonatal lesions of the medial temporal lobe disrupt prefrontal cortical regulation of striatal dopamine.
Saunders RC; Kolachana BS; Bachevalier J; Weinberger DR
Nature; 1998 May; 393(6681):169-71. PubMed ID: 9603519
[TBL] [Abstract][Full Text] [Related]
11. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.
Kegeles LS; Abi-Dargham A; Frankle WG; Gil R; Cooper TB; Slifstein M; Hwang DR; Huang Y; Haber SN; Laruelle M
Arch Gen Psychiatry; 2010 Mar; 67(3):231-9. PubMed ID: 20194823
[TBL] [Abstract][Full Text] [Related]
12. Striatal dopamine receptors and transporters in monkeys with neonatal temporal limbic damage.
Heinz A; Saunders RC; Kolachana BS; Jones DW; Gorey JG; Bachevalier J; Weinberger DR
Synapse; 1999 May; 32(2):71-9. PubMed ID: 10231127
[TBL] [Abstract][Full Text] [Related]
13. N-acetyl-aspartate levels in the dorsolateral prefrontal cortex in the early years of schizophrenia are inversely related to disease duration.
Molina V; Sánchez J; Reig S; Sanz J; Benito C; Santamarta C; Pascau J; Sarramea F; Gispert JD; Misiego JM; Palomo T; Desco M
Schizophr Res; 2005 Mar; 73(2-3):209-19. PubMed ID: 15653263
[TBL] [Abstract][Full Text] [Related]
14. Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.
Kegeles LS; Abi-Dargham A; Zea-Ponce Y; Rodenhiser-Hill J; Mann JJ; Van Heertum RL; Cooper TB; Carlsson A; Laruelle M
Biol Psychiatry; 2000 Oct; 48(7):627-40. PubMed ID: 11032974
[TBL] [Abstract][Full Text] [Related]
15. Primate phencyclidine model of schizophrenia: sex-specific effects on cognition, brain derived neurotrophic factor, spine synapses, and dopamine turnover in prefrontal cortex.
Elsworth JD; Groman SM; Jentsch JD; Leranth C; Redmond DE; Kim JD; Diano S; Roth RH
Int J Neuropsychopharmacol; 2014 Oct; 18(6):. PubMed ID: 25522392
[TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus.
Yoo SY; Yeon S; Choi CH; Kang DH; Lee JM; Shin NY; Jung WH; Choi JS; Jang DP; Kwon JS
Schizophr Res; 2009 Jun; 111(1-3):86-93. PubMed ID: 19406622
[TBL] [Abstract][Full Text] [Related]
17. Prefrontal and Striatal Glutamate Differently Relate to Striatal Dopamine: Potential Regulatory Mechanisms of Striatal Presynaptic Dopamine Function?
Gleich T; Deserno L; Lorenz RC; Boehme R; Pankow A; Buchert R; Kühn S; Heinz A; Schlagenhauf F; Gallinat J
J Neurosci; 2015 Jul; 35(26):9615-21. PubMed ID: 26134644
[TBL] [Abstract][Full Text] [Related]
18. Contrasting effects of excitotoxic lesions of the prefrontal cortex on the behavioural response to D-amphetamine and presynaptic and postsynaptic measures of striatal dopamine function in monkeys.
Wilkinson LS; Dias R; Thomas KL; Augood SJ; Everitt BJ; Robbins TW; Roberts AC
Neuroscience; 1997 Oct; 80(3):717-30. PubMed ID: 9276488
[TBL] [Abstract][Full Text] [Related]
19. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
20. Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder.
Molina V; Sánchez J; Sanz J; Reig S; Benito C; Leal I; Sarramea F; Rebolledo R; Palomo T; Desco M
Eur Psychiatry; 2007 Nov; 22(8):505-12. PubMed ID: 17904824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
